hrcak mascot   Srce   HID

Stručni rad

A PATIENT WITH RHEUMATOID ARTHRITIS AND PRIMARY BILIARY CIRRHOSIS SUCCESSFULLY TREATED WITH ADALIMUMAB

Marija Bakula
Miroslav Mayer
Nada Čikeš
Branimir Anić

Puni tekst: hrvatski, pdf (120 KB) str. 0-0 preuzimanja: 128* citiraj
APA 6th Edition
Bakula, M., Mayer, M., Čikeš, N. i Anić, B. (2015). USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE. Liječnički vjesnik, 137 (1-2), 0-0. Preuzeto s https://hrcak.srce.hr/172674
MLA 8th Edition
Bakula, Marija, et al. "USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE." Liječnički vjesnik, vol. 137, br. 1-2, 2015, str. 0-0. https://hrcak.srce.hr/172674. Citirano 15.10.2019.
Chicago 17th Edition
Bakula, Marija, Miroslav Mayer, Nada Čikeš i Branimir Anić. "USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE." Liječnički vjesnik 137, br. 1-2 (2015): 0-0. https://hrcak.srce.hr/172674
Harvard
Bakula, M., et al. (2015). 'USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE', Liječnički vjesnik, 137(1-2), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172674 (Datum pristupa: 15.10.2019.)
Vancouver
Bakula M, Mayer M, Čikeš N, Anić B. USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE. Liječnički vjesnik [Internet]. 2015 [pristupljeno 15.10.2019.];137(1-2):0-0. Dostupno na: https://hrcak.srce.hr/172674
IEEE
M. Bakula, M. Mayer, N. Čikeš i B. Anić, "USPJEŠNA PRIMJENA ADALIMUMABA U BOLESNICE OBOLJELE OD REUMATOIDNOG ARTRITISA I PRIMARNE BILIJARNE CIROZE", Liječnički vjesnik, vol.137, br. 1-2, str. 0-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/172674. [Citirano: 15.10.2019.]

Sažetak
Rheumatoid arthritis and primary biliary cirrhosis coexist in up to 6-% of cases. Tumor necrosis factor alpha seems to have an important role in the pathogenesis of both diseases. Tumor necrosis factor alpha inhibitors have become an established therapeutic regimen for patients with rheumatoid arthritis. The only approved drug for primary biliary cirrhosis is ursodeoxycholic acid. We describe the case of a female patient with both rheumatoid arthritis and primary biliary cirrhosis in a long term remission of both diseases induced with adalimumab. This case report is an important addendum to a few published similar reports.

Ključne riječi
Arthritis, rheumatoid – complications, drug therapy; Liver cirrhosis, biliary – complications, drug therapy; Tumor necrosis factor-alpha – antagonists and inhibitors; Antibodies, monoclonal, humanized – therapeutic use

Hrčak ID: 172674

URI
https://hrcak.srce.hr/172674

[hrvatski]

Posjeta: 242 *